KR20220079651A - 진통 및 마취 펩티드 및 기타 제제 - Google Patents

진통 및 마취 펩티드 및 기타 제제 Download PDF

Info

Publication number
KR20220079651A
KR20220079651A KR1020227015696A KR20227015696A KR20220079651A KR 20220079651 A KR20220079651 A KR 20220079651A KR 1020227015696 A KR1020227015696 A KR 1020227015696A KR 20227015696 A KR20227015696 A KR 20227015696A KR 20220079651 A KR20220079651 A KR 20220079651A
Authority
KR
South Korea
Prior art keywords
peptide
pain
injection
animals
peptides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
KR1020227015696A
Other languages
English (en)
Korean (ko)
Inventor
아린담 바타차르지
Original Assignee
더 리서치 파운데이션 포 더 스테이트 유니버시티 오브 뉴욕
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 더 리서치 파운데이션 포 더 스테이트 유니버시티 오브 뉴욕 filed Critical 더 리서치 파운데이션 포 더 스테이트 유니버시티 오브 뉴욕
Publication of KR20220079651A publication Critical patent/KR20220079651A/ko
Ceased legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7088—Compounds having three or more nucleosides or nucleotides
    • A61K31/7105—Natural ribonucleic acids, i.e. containing only riboses attached to adenine, guanine, cytosine or uracil and having 3'-5' phosphodiester links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A61P23/02—Local anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Anesthesiology (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
KR1020227015696A 2019-10-10 2020-10-12 진통 및 마취 펩티드 및 기타 제제 Ceased KR20220079651A (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962913512P 2019-10-10 2019-10-10
US62/913,512 2019-10-10
PCT/US2020/055289 WO2021072392A1 (en) 2019-10-10 2020-10-12 Analgesic and anesthetic peptides and other agents

Publications (1)

Publication Number Publication Date
KR20220079651A true KR20220079651A (ko) 2022-06-13

Family

ID=75437541

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020227015696A Ceased KR20220079651A (ko) 2019-10-10 2020-10-12 진통 및 마취 펩티드 및 기타 제제

Country Status (10)

Country Link
US (1) US20240294571A1 (enExample)
EP (1) EP4051690A4 (enExample)
JP (1) JP2022551467A (enExample)
KR (1) KR20220079651A (enExample)
CN (1) CN114829372A (enExample)
AU (1) AU2020364246A1 (enExample)
BR (1) BR112022006862A2 (enExample)
CA (1) CA3157686A1 (enExample)
IL (1) IL292102A (enExample)
WO (1) WO2021072392A1 (enExample)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2025029752A2 (en) * 2023-07-28 2025-02-06 Gate Science, Inc. Methods and systems for pain management and testing thereof

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU733719B2 (en) * 1996-10-23 2001-05-24 Trustees Of The University Of Pennsylvania, The Improved vaccines
IL136076A0 (en) * 1997-11-26 2001-05-20 Zymogenetics Inc Mammalian cytokin-like polypeptide -10
KR20030069989A (ko) * 2000-09-08 2003-08-27 다이이찌 산토리 파마 가부시키가이샤 심부전 치료제
PL2211873T3 (pl) * 2007-10-22 2013-01-31 Amorphical Ltd Stabilny amorficzny węglan wapnia wchodzący w skład fosforylowanych aminokwasów
WO2012019192A2 (en) * 2010-08-06 2012-02-09 Mount Sinai School Of Medicine Cell-permeable molecules as growth factor receptor antagonists
CN111712252A (zh) * 2017-12-13 2020-09-25 纽约州立大学研究基金会 用于治疗疼痛和提高疼痛敏感性的肽和其它药剂
CN112218650A (zh) * 2018-01-15 2021-01-12 单侧Ip私人有限公司 肽及其用途

Also Published As

Publication number Publication date
CN114829372A (zh) 2022-07-29
JP2022551467A (ja) 2022-12-09
CA3157686A1 (en) 2021-04-15
AU2020364246A1 (en) 2022-05-12
US20240294571A1 (en) 2024-09-05
IL292102A (en) 2022-06-01
WO2021072392A1 (en) 2021-04-15
BR112022006862A2 (pt) 2022-07-05
EP4051690A1 (en) 2022-09-07
EP4051690A4 (en) 2024-01-17

Similar Documents

Publication Publication Date Title
Bourinet et al. Silencing of the Cav3. 2 T-type calcium channel gene in sensory neurons demonstrates its major role in nociception
AU2019314383B2 (en) Engineered hemichannels, engineered vesicles, and uses thereof
Powell et al. Inhibiting endocytosis in CGRP+ nociceptors attenuates inflammatory pain-like behavior
US12077610B2 (en) Peptides and other agents for treating pain and increasing pain sensitivity
JP2012522762A (ja) ケラチノサイトの増殖および分化を調節する方法
CA2941357A1 (en) Non-narcotic crmp2 peptides targeting sodium channels for chronic pain
Jiang et al. Cardiac-specific overexpression of Claudin-5 exerts protection against myocardial ischemia and reperfusion injury
CN105848720A (zh) 用于诱导葡萄糖摄取的方法
US12514875B2 (en) Pharmaceutical composition comprising isolated mitochondria for preventing or treating tendinopathy
KR20220079651A (ko) 진통 및 마취 펩티드 및 기타 제제
Zhang et al. Differential roles of GluN2B in two types of chemical-induced long term potentiation-mediated phosphorylation regulation of GluA1 at serine 845 in hippocampal slices
KR20130027016A (ko) 포유류와 인간 세포에서 ｈｉｖ 복제를 억제하는 방법
WO2006135783A2 (en) Compositions and methods for modulating angiogenesis
Lai et al. CtBP1 is essential for epigenetic silencing of μ-opioid receptor genes in the dorsal root ganglion in spinal nerve ligation-induced neuropathic pain
US20240173376A1 (en) Trem-1 inhibitors for the treatment of marfan syndrome
JP5835699B2 (ja) 瘢痕化抑制と線維症治療を目的とする組成物と方法
CN116710474A (zh) 肽制剂及其眼科用途
RU2820132C2 (ru) Способ улучшения симптомов со стороны нижних мочевыводящих путей
US20250064846A1 (en) Treatment and prevention of trigeminal neuralgia
Powell II Nociceptor Endocytosis Regulates Inflammatory Pain
Lim Differential expression of Connexin 43 during dental pulp inflammation and its role in pulpal healing: a translational study determining effect of Connexin 43 downregulation in treatment of pulpitis
WO2025102083A1 (en) Compositions and methods for treating pain or for increasing pain sensitivity
WO2021022228A1 (en) Methods and compositions for treating and preventing damage to skin
Thakor Development of a novel sensory neuron gene delivery platform with concomitant investigation of messenger ribonucleic acid translocation for the NaV1. 8 sodium channel during neuropathic pain

Legal Events

Date Code Title Description
PA0105 International application

St.27 status event code: A-0-1-A10-A15-nap-PA0105

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

D21 Rejection of application intended

Free format text: ST27 STATUS EVENT CODE: A-1-2-D10-D21-EXM-PE0902 (AS PROVIDED BY THE NATIONAL OFFICE)

PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

B15 Application refused following examination

Free format text: ST27 STATUS EVENT CODE: N-2-6-B10-B15-EXM-PE0601 (AS PROVIDED BY THE NATIONAL OFFICE)

PE0601 Decision on rejection of patent

St.27 status event code: N-2-6-B10-B15-exm-PE0601